Dark

Check out our Dark Pool Levels

CAHC
CA Healthcare Acquisition Corp. Class A Common Stock
stock NASDAQ

Inactive

Sep 28, 2021

9.94USD-1.972%(-0.20)1,383,727

Pre-market

0.00USD-100.000%(-10.14)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Sep 29, 2021

08:13AM EDT The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug Benzinga

Sep 28, 2021

06:55PM EDT LumiraDx to Become Publicly Traded following Successful Closing of Merger with CA Healthcare Acquisition Corp. Business Wire

Sep 7, 2021

04:28PM EDT CA Healthcare Acquisition Corp. and LumiraDx Limited Announce Effectiveness of Registration Statement and September 28, 2021 Special Meeting to Approve Business Combination Business Wire

Aug 31, 2021

11:44AM EDT Benzinga's Top Ratings Upgrades, Downgrades For August 31, 2021 Benzinga

08:07AM EDT Ladenburg Thalmann Initiates Coverage On CA Healthcare Acquisition with Buy Rating Benzinga

Aug 20, 2021

03:49PM EDT Dwindling COVID-19 Test Demand Forces LumiraDx Cut SPAC Deal Value Benzinga

08:04AM EDT LumiraDx, CA Healthcare Acquisition Corp. Report Lowered Transaction Terms Adjust LumiraDx's Valuation From $5B To $3B Benzinga

08:00AM EDT LumiraDx and CA Healthcare Acquisition Corp Revise Transaction Terms, Expanded Strategic Roadmap for Next-Generation Point-of-Care Diagnostics Business Wire

Apr 11, 2021

06:28PM EDT SPACs Attack Weekly Recap: 6 Deals, Rumors And Headline News Benzinga

Apr 7, 2021

12:23PM EDT LumiraDx Withdraws $100M IPO In Favor Of $5B SPAC Merger: Bloomberg Benzinga

01:05AM EDT CA Healthcare Acquisition Announces Definitive Merger Agreement With LumiraDx RTTNews

01:00AM EDT LumiraDx, a Next-Generation Point of Care Diagnostics Testing Company to List on Nasdaq via Merger with CA Healthcare Acquisition Corp Business Wire

Share